Lab-on-a-chip for oral cancer screening and diagnosis
✍ Scribed by Barry L. Ziober; Michael G. Mauk; Erica M. Falls; Zongyuan Chen; Amy F. Ziober; Haim H. Bau
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 816 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Oral squamous cell carcinoma (OSCC) is a disfiguring and deadly cancer. Despite advances in therapy, many patients continue to face a poor prognosis. Early detection is an important factor in determining the survival of patients with OSCC. No accurate, cost‐efficient, and reproducible method exists to screen patients for OSCC. As a result, many patients are diagnosed at advanced stages of the disease. Early detection would identify patients, facilitating timely treatment and close monitoring. Mass screening requires a rapid oral cancer diagnostic test that can be used in a clinical setting. Current diagnostic techniques for OSCC require modern laboratory facilities, sophisticated equipment, and elaborate and lengthy processing by skilled personnel. The lab‐on‐chip technology holds the promise of replacing these techniques with miniaturized, integrated, automated, inexpensive diagnostic devices. This article describes lab‐on‐chip devices for biomarker‐based identification of oral cancer. Similar methods can be employed for the screening of other types of cancers. © 2007 Wiley Periodicals, Inc. Head Neck, 2008
📜 SIMILAR VOLUMES
## Abstract In this work, the development of a packed immobilized enzyme reactor (IMER) and its integration to a capillary electrophoresis microchip is described. The present microchip design differs from others, in the fact that the same design could be used with or without the particles and, just
The 4th workshop of the UICC project on screening for cancer was held in Helsinki, Finland on April 7-9, 1986. In developed countries there are more data available from controlled trials on the effectiveness of screening for breast cancer than for any other cancer. Nevertheless, full information is